Background: In selected metastatic renal cell carcinoma (mRCC) patients, radical metastasectomy followed by observation is a potential strategy. It is still to be defined whether systemic therapy should be administered following metastasectomy. ...
The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.
I am so proud of our #IMDC fellows. Thanks for all your hard work, stats, perfecting slides, and for informing practice. #GU20 @asco #SFO #oncoalert @UCalgaryMed @KidneyCancer_Ca @DanaFarber https://t.co/JDEh7HKcLp
looking forward to see the combination w anti PD1 in earlier setting. Kidney is being transformed. @DrChoueiri https://t.co/4v8TQow73m
Check out https://t.co/oGYJLoPzND! Includes #IMDC criteria calculator for met #kidneycancer risk group, all IMDC publications / upcoming posters, and profiles of our amazing fellows! Thx to @ShaanDudani for creating it #bestpresentever! Perfect timing ahead of #GU20 @ASCO!
